This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: University of Miami, Rxmp Therapeutics, Inc.. Active years: 1988-2022.
Location History:
- Miami, FL (US) (1988 - 2015)
- Pinecrest, FL (US) (2022)
Company Filing History:
Years Active: 1988-2022
Title: Yeon S Ahn: Innovator in Hemostatic Treatments
Introduction
Yeon S Ahn is a prominent inventor based in Miami, FL (US), known for his significant contributions to the field of medical innovations. With a total of 6 patents, Ahn has focused on developing advanced treatments for excessive bleeding, showcasing his expertise in biomedical engineering.
Latest Patents
Ahn's latest patents include a composition comprising red cell-derived microparticles and a method for treating excessive bleeding. This innovative composition demonstrates acetylcholine esterase (AchE) activity of less than 350 pmol/min/10 particles/uL. The method involves administering this composition to a subject to effectively manage excessive bleeding. Another notable patent expands the utility of red blood cell membrane-derived microparticles (RMP) as safe and economical hemostatic agents. These microparticles can be produced using a high-pressure extrusion membrane shear process and retain their activity even when stored at room temperature. RMP can be administered to original donors or blood type compatible recipients, making them versatile in treating various bleeding conditions.
Career Highlights
Throughout his career, Yeon S Ahn has worked with esteemed institutions such as the University of Miami and Rxmp Therapeutics, Inc. His work has significantly impacted the development of hemostatic agents, providing solutions for trauma, surgeries, and bleeding disorders.
Collaborations
Ahn has collaborated with notable professionals in his field, including Wenche Jy and William J Harrington, Jr. These partnerships have furthered his research and innovations in medical treatments.
Conclusion
Yeon S Ahn's contributions to the field of hemostatic treatments highlight his dedication to improving patient care through innovative solutions. His work continues to pave the way for advancements in medical technology and treatment methodologies.